Federal Court Overturns Gilead Sciences and Merck Patent Dispute Post author:Sam Post published:February 19, 2018 Post category:BioPharma Federal court judge orders Merck to repay $2.5 Billion to Gilead in overturned patent decision. Source: BioSpace You Might Also Like Frazier-Backed Mavupharma Scores $20M to Fund STING Program November 28, 2017 VEXIM Acquired by Stryker in EUR 183M Deal October 24, 2017 Two Former Ariad Directors Charged With Insider Trading June 27, 2017